The controversy surrounding AI pioneer Geoffrey Hinton’s Nobel Prize misses the point
Here’s how Dell and IBM are using AI in their social and environmental efforts
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Tesla’s soon-to-be-unveiled robotaxi may already be behind its Chinese competition
Trump advisor proposes a shadow Fed chair, but Wall Street veteran Ed Yardeni thinks it’s a recipe for disaster
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
Trump’s odds have surged over the past week and he now holds a 2 vote electoral college lead, says prominent data scientist
French workers are taking more sick leave than ever, but the government can’t afford to foot the bill
